Every one of those 1 sits in a single category, pharma. Guardian Pharmacy Services, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Ur-Energy Inc., all published on March 13, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Ur-Energy Inc.
Every one of those 1 sits in a single category, pharma. Guardian Pharmacy Services, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Ur-Energy Inc., all published on March 13, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Ur-Energy Inc.. Shared-story counts are live from our verified record — not editorial picks.
Guardian Pharmacy Services (NYSE:GRDN) significantly outperformed analyst expectations in its fourth-quarter 2025 earnings report, posting an EPS of $0.3289 against a consensus of $0.2675. The results underscore the resilience of the company's decentralized 'local-autonomy' model within the high-growth long-term care pharmacy sector.
Ur-Energy Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.